Phenotype
|
Fish
|
Conditions
|
Figures
|
midbrain hindbrain boundary morphology, ameliorated
|
AB/TU + MO1-dis3l2
|
chemical treatment by environment: SC79
|
Fig. 3
from D'Silva et al., 2025
|
cranial neural crest twist1a expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
whole organism bcl2l11 expression increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
brain apoptotic process process quality, ameliorated
|
AB/TU + MO1-dis3l2
|
chemical treatment by environment: SC79
|
Fig. 3
from D'Silva et al., 2025
|
midbrain hindbrain boundary absence of anatomical entity, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1 ,
Fig. 3
from D'Silva et al., 2025
|
cranial cartilage morphology, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1
from D'Silva et al., 2025
|
brain deformed, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1 ,
Fig. 3
from D'Silva et al., 2025
|
midbrain hindbrain boundary pax2a expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
whole organism viability, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1
from D'Silva et al., 2025
|
blastomere mitotic spindle ab3-tuba labeling spatial pattern, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
cranial neural crest foxd3 expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
blastomere spindle pole Ab8-tubg1 labeling spatial pattern, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
brain anatomical structure quality, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1 ,
Fig. 3
from D'Silva et al., 2025
|
eye deformed, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1 ,
Fig. 3
from D'Silva et al., 2025
|
midbrain morphology, ameliorated
|
AB/TU + MO1-dis3l2
|
chemical treatment by environment: SC79
|
Fig. 3
from D'Silva et al., 2025
|
blastomere mitotic nuclear bridge increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
eye morphology, ameliorated
|
AB/TU + MO1-dis3l2
|
chemical treatment by environment: SC79
|
Fig. 3
from D'Silva et al., 2025
|
whole organism Ab3-cdk1 labeling increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
otic vesicle pax2a expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
whole organism cdkn1ba expression increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
whole organism cdkn1a expression increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
neural tube apoptotic process increased process quality, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
hindbrain anatomical structure quality, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1 ,
Fig. 3
from D'Silva et al., 2025
|
forebrain morphology, ameliorated
|
AB/TU + MO1-dis3l2
|
chemical treatment by environment: SC79
|
Fig. 3
from D'Silva et al., 2025
|
brain morphology, ameliorated
|
AB/TU + MO1-dis3l2
|
chemical treatment by environment: SC79
|
Fig. 3
from D'Silva et al., 2025
|
brain apoptotic process increased process quality, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
whole organism Ab15-casp3 labeling increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
neural tube apoptotic process process quality, ameliorated
|
AB/TU + MO1-dis3l2
|
chemical treatment by environment: SC79
|
Fig. 3
from D'Silva et al., 2025
|
pericardium edematous, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1
from D'Silva et al., 2025
|
blastomere spindle pole distributed, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
neural crest sox10 expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
forebrain anatomical structure quality, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1 ,
Fig. 3
from D'Silva et al., 2025
|
whole organism foxo3a expression increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
whole organism ab10-akt labeling increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
whole organism ccnd1 expression increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
whole organism cdkn1bb expression increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
whole organism Ab1-dis3l2 labeling decreased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1
from D'Silva et al., 2025
|
eye pax2a expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
optic stalk pax2a expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
head decreased area, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
forebrain undulate, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1 ,
Fig. 3
from D'Silva et al., 2025
|
whole organism bbc3 expression increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
midbrain hindbrain boundary fgf8a expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
whole organism Ab3-mek1 labeling decreased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
whole organism Ab3-casp9 labeling increased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
blastomere metaphase chromosome alignment decreased process quality, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
trunk neural crest crestin expression increased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
eye fgf8a expression decreased distribution, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 2
from D'Silva et al., 2025
|
whole organism ab3-gsk3b labeling decreased amount, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 3
from D'Silva et al., 2025
|
midbrain anatomical structure quality, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 1 ,
Fig. 3
from D'Silva et al., 2025
|
hindbrain morphology, ameliorated
|
AB/TU + MO1-dis3l2
|
chemical treatment by environment: SC79
|
Fig. 3
from D'Silva et al., 2025
|
blastomere mitotic spindle elongated, abnormal
|
AB/TU + MO1-dis3l2
|
control
|
Fig. 4
from D'Silva et al., 2025
|
pronephros development disrupted, abnormal
|
WT + MO1-dis3l2
|
standard conditions
|
Fig. S11
from Astuti et al., 2012
|
pronephric duct opening morphology, abnormal
|
WT + MO1-dis3l2
|
standard conditions
|
Fig. S11
from Astuti et al., 2012
|
cloaca development disrupted, abnormal
|
WT + MO1-dis3l2
|
standard conditions
|
Fig. S11
from Astuti et al., 2012
|
pericardium edematous, abnormal
|
WT + MO1-dis3l2
|
standard conditions
|
Fig. S11
from Astuti et al., 2012
|